We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Infliximab for diabetic macular edema refractory to laser photocoagulation: a randomized, double-blind, placebo-controlled, crossover, 32-week study.
- Authors
Sfikakis, Petros P; Grigoropoulos, Vlassis; Emfietzoglou, Ioannis; Theodossiadis, George; Tentolouris, Nicholas; Delicha, Evi; Katsiari, Christina; Alexiadou, Kleopatra; Hatziagelaki, Erifili; Theodossiadis, Panayiotis G
- Abstract
Because many patients with diabetic macular edema (DME) do not respond to focal/grid laser photocoagulation, the only currently approved treatment, alternatives are needed. Based on encouraging preliminary findings, we aimed to assess efficacy and safety of the anti-tumor necrosis factor (TNF) monoclonal antibody infliximab in this condition.
- Publication
Diabetes care, 2010, Vol 33, Issue 7, p1523
- ISSN
1935-5548
- Publication type
Journal Article
- DOI
10.2337/dc09-2372